Distribution and relationships between clinical and biopathological parameters in canine leishmaniasis.
Although the lesions, clinical signs and biochemical alterations observed in the course of canine leishmaniasis have been amply described a thorough definition and characterisation of the affected populations is important in order to detect relationships between parameters which may be involved in the development of this disease and to correctly assess further studies. This study included 61 dogs diagnosed with naturally acquired canine leishmaniasis by means of indirect immunofluorescence assay (IFA). At diagnosis, dogs were classified according to the following qualitative and quantitative variables: gender, breed, age, clinical picture, antibody titre, serum protein electrophoretogram, haemogram (CBC), urea, creatinine and ALT. Our population included dogs of 24 breeds, both sexes and different ages indicating no sex, age or breed predilection. In relation to the clinical picture, eight dogs were asymptomatic, 16 displayed mainly cutaneous signs, 18 presented primarily visceral signs and 19 displayed both cutaneous and visceral signs. Our results indicate that the clinical picture is significantly related to electrophoretogram and to RBC, PCV and haemoglobin. Dogs with mainly cutaneous signs showed the highest eosinophil mean values and those with mainly visceral signs showed the highest alpha-globulin mean values. This study confirms that the antibody titre is highly correlated with electrophoretogram and with RBC, PCV and haemoglobin. Lymphocytes were not associated or correlated with any other variable considered. PMNC, monocytes and eosinophils, as well as WBC, showed a significant correlation with beta-globulins, which is difficult to interpret.
Dpto. Patología Animal II, Facultad de Veterinaria, Universidad Complutense de Madrid, Spain. angelehr@eucmax.sim.ucm.es
I
I
Amusategui
A
A
Sainz
F
F
Rodríguez
M A
MA
Tesouro
D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis; D004283:Dog Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D004285:Dogs; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect / Q000662:veterinary; D007896:Leishmaniasis / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology / Q000662:veterinary*; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis / Q000453:epidemiology / Q000662:veterinary; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000453:epidemiology / Q000662:veterinary; D008297:Male; D016036:Seroepidemiologic Studies; D013030:Spain / Q000453:epidemiology
D000913:Antibodies, Protozoan